Casi Pharmaceuticals Inc (CASI)
2.30 unch (unch) 03/20/25 [NASDAQ]
1.85 x 100 3.00 x 1,000
Realtime by (Cboe BZX)
1.85 x 100 3.00 x 1,000
Realtime - - (-) -
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -40,257 | -20,916 | -15,893 |
| Depreciation Amortization | N/A | N/A | 2,422 | 1,532 | 767 |
| Accounts receivable | N/A | N/A | -3,170 | -2,757 | -457 |
| Accounts payable and accrued liabilities | N/A | N/A | 1,066 | -1,073 | 236 |
| Other Working Capital | N/A | N/A | -5,461 | -8,464 | -5,134 |
| Other Operating Activity | -13,199 | 0 | 24,312 | 11,433 | 6,760 |
| Operating Cash Flow | $-13,199 | $N/A | $-21,088 | $-20,245 | $-13,721 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,503 | N/A | -4,527 | N/A | N/A |
| PPE Investments | -53 | N/A | -5,474 | -2,186 | -1,719 |
| Net Acquisitions | N/A | N/A | -2,898 | -2,962 | -2,962 |
| Sale Of Investment | N/A | N/A | 37,622 | 1,294 | 1,294 |
| Purchase Sale Intangibles | -36 | N/A | N/A | 138 | 138 |
| Other Investing Activity | -36 | 0 | 6,436 | 17,059 | 138 |
| Investing Cash Flow | $-16,592 | $N/A | $31,159 | $13,205 | $-3,249 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,001 | 4,001 | 1,001 |
| Debt Repayment | N/A | N/A | -4,001 | -1,001 | N/A |
| Common Stock Issued | 109 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -278 | N/A | -3,267 | -3,000 | -3,000 |
| Financing Cash Flow | $-169 | $N/A | $-3,267 | $N/A | $-1,999 |
| Exchange Rate Effect | -237 | N/A | 1,604 | -2,422 | -873 |
| Beginning Cash Position | 47,112 | N/A | 38,704 | 38,704 | 38,704 |
| End Cash Position | 16,915 | N/A | 47,112 | 29,242 | 18,862 |
| Net Cash Flow | $-30,197 | $N/A | $8,408 | $-9,462 | $-19,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,199 | N/A | -21,088 | -20,245 | -13,721 |
| Capital Expenditure | -53 | N/A | -5,612 | -2,186 | -1,719 |
| Free Cash Flow | -13,252 | 0 | -26,700 | -22,431 | -15,440 |